Login
$OKUR
$2.75 +$0.12 (4.56%) Live

$OKUR SEC Filings

Filed On Filing
04 Nov 2026 8-K: Results of Operations and Financial Condition

-- Announces PANORAMA, an OnKure-sponsored, large-scale, multiregional registry designed to characterize the natural disease course and treatment patterns of people living with vascular anomalies

04 Nov 2026 10-Q
07 Oct 2026 SCHEDULE 13G
23 Sep 2026 Form 4: Saccomano Nicholas A, Director

Sold 87 shares ($259)

23 Sep 2026 Form 4: Leverone Jason A., Chief Financial Officer

Sold 302 shares ($898)

14 Aug 2026 SCHEDULE 13G/A
14 Aug 2026 SCHEDULE 13G/A
14 Aug 2026 SCHEDULE 13G/A
13 Aug 2026 Form 4/A: Manke Isaac, Director

Holds 15,300 Stock Option (right to buy) (exercise price $18.20, expires Oct 3, 2034)

13 Aug 2026 8-K: Departure/Election of Directors or Officers; Compensation

On August 7, 2026 (the “Effective Date”), the Board of Directors (the “Board”) of OnKure Therapeutics, Inc. (the “Company”) approved an option repricing. The repricing generally applied to all outstanding and unexercised stock options to...

11 Aug 2026 Form 4: Mathers Edward T, Director

Granted 22,350 Stock Option (right to buy)

11 Aug 2026 Form 4: Ratcliffe Liam, Director

Granted 22,350 Stock Option (right to buy)

11 Aug 2026 Form 4: Phillips Andrew John, Director

Granted 22,350 Stock Option (right to buy)

11 Aug 2026 Form 4: Manke Isaac, Director

Granted 315,300 Stock Option (right to buy) · Disposed of 15,300 Stock Option (right to buy) (Disposition to Issuer)

11 Aug 2026 Form 4: Jansen Valerie Malyvanh, Director

Granted 22,350 Stock Option (right to buy)

11 Aug 2026 Form 4: Grey Michael G, Director

Granted 22,350 Stock Option (right to buy)

11 Aug 2026 Form 4: Carruthers R Michael, Director

Granted 22,350 Stock Option (right to buy)

11 Aug 2026 Form 4: Saccomano Nicholas A, Director

Granted 721,423 Employee Stock Option (right to buy) · Disposed of 571,423 Employee Stock Option (right to buy) (Disposition to Issuer)

11 Aug 2026 Form 4: Leverone Jason A., Chief Financial Officer

Granted 185,933 Employee Stock Option (right to buy) · Disposed of 5,781 Employee Stock Option (right to buy (Disposition to Issuer) · Granted 5,781 Employee Stock Option (right to buy · 1 more

11 Aug 2026 Form 4: Hartley Dylan, Chief Scientific Officer

Granted 187,603 Employee Stock Option (right to buy) · Disposed of 137,603 Employee Stock Option (right to buy) (Disposition to Issuer)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support